Suppr超能文献

基于结构的趋化因子受体CXCR4拮抗剂的开发

Structure-based development of antagonists for chemokine receptor CXCR4.

作者信息

Zhang Chongqian, Hou Tingjun, Feng Zhiwei, Li Youyong

机构信息

Institute of Functional Nano & Soft Materials and Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Soochow University, Suzhou, Jiangsu, China.

出版信息

Curr Comput Aided Drug Des. 2013 Mar;9(1):60-75.

Abstract

The C-X-C chemokine receptor-4(CXCR4) is a G-protein coupled receptor (GPCR) which belongs to the family I GPCR or rhodopin-like GPCR family. CXCR4 plays a crucial role as a co-receptor with CCR5 for HIV-1 anchoring to mammalian cell membrane, and is implicated in cancer metastasis and inflammation. Recently, crystal structure of human CXCR4 receptor was reported, which facilitates the structure-based drug discovery of CXCR4 significantly. Here we summarize the structure feature of C-X-C chemokine and its difference from other rhodopsin-like GPCR family, the impact of recent crystal structure on CXCR4 drug development, the available active compounds for CXCR4 receptor, SAR studies of the available active compounds, the recognition mechanism of the inhibitors of CXCR4 receptor (molecular docking results and molecular dynamics results), which illustrates the interaction between the inhibitors and critical residues of CXCR4, and the outlook of drug development for CXCR4 receptor.

摘要

CXC趋化因子受体4(CXCR4)是一种G蛋白偶联受体(GPCR),属于I类GPCR或视紫红质样GPCR家族。CXCR4作为HIV-1锚定到哺乳动物细胞膜的共受体与CCR5发挥关键作用,并与癌症转移和炎症有关。最近,报道了人CXCR4受体的晶体结构,这极大地促进了基于结构的CXCR4药物发现。在此,我们总结了CXC趋化因子的结构特征及其与其他视紫红质样GPCR家族的差异、最近晶体结构对CXCR4药物开发的影响、CXCR4受体可用的活性化合物、可用活性化合物的构效关系研究、CXCR4受体抑制剂的识别机制(分子对接结果和分子动力学结果),这阐明了抑制剂与CXCR4关键残基之间的相互作用,以及CXCR4受体药物开发的前景。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验